Generation of a Live Attenuated Influenza a Vaccine by Proteolysis Targeting

The authors described the generation of a live attenuated influenza A virus vaccine using proteolysis-targeting chimeric technology to degrade viral proteins via the endogenous ubiquitin–proteasome system of host cells.